Lucentis and Motrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Motrin (ibuprofen). Common drug interactions include vision blurred among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Motrin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Motrin?

Motrin has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 38,332 Motrin users. Check the latest studies of Motrin.

On Jul, 13, 2026

13 people who take Lucentis and Motrin together, and have interactions are studied.

What are the common drug interactions of Lucentis and Motrin, by gender? *:

female:

Vision blurred
Vitreous floaters (spots before the eyes)
Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
Blood glucose increased
Neuralgia (pain in one or more nerves)
Visual acuity reduced (reduced clearness of vision)
Abdominal discomfort
Abdominal distension
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Decreased appetite

male:

Abdominal discomfort
Abdominal distension
Fall
Herpes simplex (herpes simplex is a common viral infection)
Immunodeficiency
Inflammation
Joint dislocation (a joint position is changed from normal position)
Malaise (a feeling of general discomfort or uneasiness)
Neoplasm (tumour)
Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Lucentis and Motrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood glucose increased
Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
Neuralgia (pain in one or more nerves)
Vision blurred
Visual acuity reduced (reduced clearness of vision)
Fatigue (feeling of tiredness)
Photopsia (presence of perceived flashes of light)
Retinal haemorrhage (bleeding from retina)
Vitreous floaters (spots before the eyes)

40-49:

n/a

50-59:

n/a

60+:

Cardiac failure congestive
Pneumonia
Blood creatine phosphokinase increased
Bone erosion
Breast cancer in situ
Cardiac disorder
Cerebral haemorrhage (bleeding within the brain)
Death
Depressed mood
Diarrhoea

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 4 people, 30.77%
Stress And Anxiety: 3 people, 23.08%
High Blood Pressure: 3 people, 23.08%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 3 people, 23.08%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 23.08%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 15.38%
Diarrhea: 2 people, 15.38%
Indigestion: 2 people, 15.38%
Joint Pain: 2 people, 15.38%
Mydriasis (a dilation of the pupil): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Motrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously